Establishment Labs (ESTA) Projected to Post Quarterly Earnings on Wednesday

Establishment Labs (NASDAQ:ESTA) is expected to be announcing its earnings results after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of ($0.64) per share and revenue of $44.45 million for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Establishment Labs Stock Performance

Establishment Labs stock opened at $33.41 on Monday. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. The company’s 50-day moving average is $37.89 and its 200 day moving average is $41.43. Establishment Labs has a 1-year low of $28.16 and a 1-year high of $60.12. The firm has a market capitalization of $935.56 million, a P/E ratio of -12.95 and a beta of 1.12.

Analyst Ratings Changes

Separately, Stephens upgraded shares of Establishment Labs to a “strong-buy” rating in a report on Monday, December 2nd. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $60.60.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.